The Alopecia Areata research grant from Pfizer supports basic and clinical research to increase clinical and scientific knowledge of the use of ritlecitinib in alopecia areata (AA). The institution and principal investigator (PI) must be based in the United States. The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy. Applicant must be affiliated with a host institution.
Applicants may apply for up to 400,000 USD for up to 2 years (including 28% indirect costs).
Applications are due on June 26, 2023.
June 26, 2023